arginine has been researched along with Dwarfism, Thanatophoric in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonaventure, J; Freisinger, P; Nerlich, AG | 1 |
| Baffico, M; Baldi, M; Camera, G; Pozzolo, S | 1 |
| Kruczek, A; Kruczek, P; Mitkowska, Z; Pietrzyk, JJ | 1 |
3 other study(ies) available for arginine and Dwarfism, Thanatophoric
| Article | Year |
|---|---|
Radiological and histological variants of thanatophoric dysplasia are associated with common mutations in FGFR-3.
Topics: Adult; Arginine; Bone and Bones; Cartilage; Cysteine; Diagnosis, Differential; Female; Fetus; Genetic Variation; Gestational Age; Humans; Infant, Newborn; Phenotype; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Pregnancy; Protein-Tyrosine Kinases; Radiography; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Thanatophoric Dysplasia; Tyrosine | 1996 |
An unusual radiological finding in thanatophoric dysplasia type 1 with common mutation of the fibroblast growth factor receptor-3 (FGFR3) gene (Arg248Cys)
Topics: Arginine; Cystine; Fetus; Gestational Age; Humans; Mutation; Protein-Tyrosine Kinases; Radiography; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Thanatophoric Dysplasia | 1997 |
[Thanatophoric dysplasia: three patients hospitalized in PAIP in 1994-2000].
Topics: Arginine; Cysteine; DNA Mutational Analysis; Fatal Outcome; Hospitalization; Humans; Infant, Newborn; Male; Point Mutation; Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Thanatophoric Dysplasia | 2002 |